Testing effectiveness (Phase 2)Study completedNCT00428896
What this trial is testing
A Feasibility Study With Iressa in Resistant Cytokeratin-Positive Tumor Cells Circulating in the Blood of Women With Breast Cancer
Who this might be right for
Breast Cancer
University Hospital of Crete 24